Guardian Therapeutics is a biotechnology company focused on discovering and developing aptamer therapeutics. Aptamers are short nucleic acids that can bind to specific target molecules through various interactions, allowing for precise therapeutic applications. The company aims to harness the potential of these aptamer-based technologies to enhance treatment options for patients, positioning itself as a leader in the field of aptamer therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.